Middle East & Africa Allergy Immunotherapy Market Size & Outlook
Middle East & Africa allergy immunotherapy market, 2016-2027 (US$M)
Related Markets
MEA allergy immunotherapy market highlights
- The MEA allergy immunotherapy market generated a revenue of USD 36.4 million in 2019.
- The market is expected to grow at a CAGR of 5.4% from 2020 to 2027.
- In terms of segment, subcutaneous immunotherapy was the largest revenue generating treatment type in 2019.
- Sublingual immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2020 to 2027.
MEA data book summary
| Market revenue in 2019 | USD 36.4 million |
| Market revenue in 2027 | USD 55.4 million |
| Growth rate | 5.4% (CAGR from 2019 to 2027) |
| Largest segment | Subcutaneous immunotherapy |
| Fastest growing segment | Sublingual immunotherapy |
| Historical data covered | 2016 - 2018 |
| Base year for estimation | 2019 |
| Forecast period covered | 2020 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Subcutaneous immunotherapy, Sublingual immunotherapy |
| Key market players worldwide | Merck KGaA, Allergy Therapeutics PLC, DBV Technologies SA ADR, ASIT biotech, Circassia, Mylan, DMK Pharmaceuticals Corp, Alk-Abello A/S Class B, Desentum, HAL Allergy Group, HollisterStier Allergy, Stallergenes Greer |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.3% of the global allergy immunotherapy market in 2019.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 255.9 million by 2027.
Key Regions: U.S. , Japan , Brazil , South Africa , Saudi Arabia
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Immunotherapy Market Scope
Allergy Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa allergy immunotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to allergy immunotherapy market will help companies and investors design strategic landscapes.
Subcutaneous immunotherapy was the largest segment with a revenue share of 84.62% in 2019. Horizon Databook has segmented the Middle East & Africa allergy immunotherapy market based on subcutaneous immunotherapy, sublingual immunotherapy covering the revenue growth of each sub-segment from 2016 to 2027.
- Middle East & Africa Allergy Immunotherapy Treatment Type Outlook (Revenue, USD Million, 2016-2027)
- Subcutaneous immunotherapy
- Sublingual immunotherapy
- Tablets
- Drops
- Middle East & Africa Allergy Immunotherapy Allergy Type Outlook (Revenue, USD Million, 2016-2027)
- Allergic Rhinitis
- Allergic Asthma
- Other Allergies
- Middle East & Africa Allergy Immunotherapy Distribution Channel Outlook (Revenue, USD Million, 2016-2027)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Reasons to subscribe to Middle East & Africa allergy immunotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa allergy immunotherapy market databook
-
Our clientele includes a mix of allergy immunotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa allergy immunotherapy market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa allergy immunotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
MEA allergy immunotherapy market size, by country, 2016-2027 (US$M)
Middle East & Africa Allergy Immunotherapy Market Share, 2019 & 2027 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
